• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。

Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.

机构信息

Vulnerable Veteran Innovative PACT (VIP) Initiative, VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.

Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation, VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.

出版信息

Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.

DOI:10.1080/08897077.2020.1787299
PMID:32697170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849630/
Abstract

The US is confronted with a rise in opioid use disorder (OUD), opioid misuse, and opioid-associated harms. Medication treatment for opioid use disorder (MOUD)-including methadone, buprenorphine and naltrexone-is the gold standard treatment for OUD. MOUD reduces illicit opioid use, mortality, criminal activity, healthcare costs, and high-risk behaviors. The Veterans Health Administration (VHA) has invested in several national initiatives to encourage access to MOUD treatment. Despite these efforts, by 2017, just over a third of all Veterans diagnosed with OUD received MOUD. VHA OUD specialty care is often concentrated in major hospitals throughout the nation and access to this care can be difficult due to geography or patient choice. Recognizing the urgent need to improve access to MOUD care, in the Spring of 2018, the VHA initiated the Stepped Care for Opioid Use Disorder, Train the Trainer (SCOUTT) Initiative to facilitate access to MOUD in VHA non-SUD care settings. The SCOUTT Initiative's primary goal is to increase MOUD prescribing in VHA primary care, mental health, and pain clinics by training providers working in those settings on how to provide MOUD and to facilitate implementation by providing an ongoing learning collaborative. Thirteen healthcare providers from each of the 18 VHA regional networks across the VHA were invited to implement the SCOUTT Initiative within one facility in each network. We describe the goals and initial activities of the SCOUTT Initiative leading up to a two-day national SCOUTT Initiative conference attended by 246 participants from all 18 regional networks in the VHA. We also discuss subsequent implementation facilitation and evaluation plans for the SCOUTT Initiative. The VHA SCOUTT Initiative could be a model strategy to implement MOUD within large, diverse health care systems.

摘要

美国正面临阿片类药物使用障碍(OUD)、阿片类药物滥用和与阿片类药物相关的危害的上升。阿片类药物使用障碍的药物治疗(MOUD)——包括美沙酮、丁丙诺啡和纳曲酮——是 OUD 的金标准治疗方法。MOUD 可减少非法阿片类药物使用、死亡率、犯罪活动、医疗保健成本和高风险行为。退伍军人健康管理局(VHA)投资了多项国家倡议,以鼓励获得 MOUD 治疗。尽管做出了这些努力,但到 2017 年,只有超过三分之一被诊断出患有 OUD 的退伍军人接受了 MOUD 治疗。VHA 的 OUD 专科护理通常集中在全国的大医院,由于地理位置或患者选择,获得这种护理可能很困难。认识到迫切需要改善 MOUD 护理的可及性,2018 年春季,VHA 启动了 Stepped Care for Opioid Use Disorder, Train the Trainer (SCOUTT) 计划,以促进 VHA 非 SUD 护理环境中 MOUD 的可及性。SCOUTT 计划的主要目标是通过培训在这些环境中工作的提供者如何提供 MOUD,并通过提供持续的学习协作来促进实施,从而增加 VHA 初级保健、心理健康和疼痛诊所中的 MOUD 处方。每个 VHA 区域网络中的 18 个网络都邀请了 13 名医疗保健提供者在每个网络中的一个设施中实施 SCOUTT 计划。我们描述了 SCOUTT 计划的目标和初步活动,该计划之前举办了为期两天的全国 SCOUTT 计划会议,来自 VHA 所有 18 个区域网络的 246 名参与者参加了会议。我们还讨论了 SCOUTT 计划的后续实施促进和评估计划。VHA 的 SCOUTT 计划可能是在大型、多样化的医疗保健系统中实施 MOUD 的一种模式策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c086/7849630/f36eb4a7132c/nihms-1657019-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c086/7849630/f36eb4a7132c/nihms-1657019-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c086/7849630/f36eb4a7132c/nihms-1657019-f0001.jpg

相似文献

1
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。
Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.
2
Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders.干预措施对同时存在和不伴物质使用障碍的患者提供阿片类使用障碍药物的影响。
J Subst Use Addict Treat. 2023 Dec;155:209175. doi: 10.1016/j.josat.2023.209175. Epub 2023 Sep 24.
3
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.农村与城市退伍军人事务部医疗机构中阿片类药物使用障碍药物的可及性。
J Gen Intern Med. 2023 Jun;38(8):1871-1876. doi: 10.1007/s11606-023-08027-4. Epub 2023 Jan 23.
4
Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.改善美国退伍军人医疗保健系统中非成瘾诊所处方行为的干预措施后,阿片类药物使用障碍药物的可及性。
JAMA Netw Open. 2021 Dec 1;4(12):e2137238. doi: 10.1001/jamanetworkopen.2021.37238.
5
Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.在同时存在物质使用问题的退伍军人中治疗阿片类药物使用障碍:在初级保健、心理健康和疼痛环境中使用丁丙诺啡的提供者的定性研究。
Addict Sci Clin Pract. 2023 May 4;18(1):26. doi: 10.1186/s13722-023-00382-1.
6
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.COVID-19 的影响以及快速放宽政策以扩大阿片类药物使用障碍(MOUD)药物获取:一项全国退伍军人健康管理局队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109678. doi: 10.1016/j.drugalcdep.2022.109678. Epub 2022 Nov 1.
7
Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.在为期一年的外部促进干预过程中,药物治疗阿片类药物使用障碍处方障碍的波动。
Addict Sci Clin Pract. 2021 Aug 6;16(1):51. doi: 10.1186/s13722-021-00259-1.
8
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
9
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.对被监禁者阿片类药物使用障碍(MOUD)药物治疗的伦理分析。
Subst Abus. 2020;41(2):150-154. doi: 10.1080/08897077.2019.1695706. Epub 2019 Dec 4.
10
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.

引用本文的文献

1
Healthcare Expenditures Associated With Implementing an External Facilitation Program to Increase the Prescribing of Medications Used for the Treatment of Opioid Use Disorder Among Veterans.与实施一项外部促进计划相关的医疗保健支出,该计划旨在增加退伍军人中用于治疗阿片类物质使用障碍的药物的处方量。
Subst Use Addctn J. 2025 Oct;46(4):901-912. doi: 10.1177/29767342251336035. Epub 2025 Apr 28.
2
Primary Care Patients With Opioid Use Disorder Symptoms: Initiation and Engagement in Treatment With Medicine.有阿片类药物使用障碍症状的基层医疗患者:药物治疗的启动与参与情况
Ann Fam Med. 2025 Jul 28;23(4):308-314. doi: 10.1370/afm.240440.
3

本文引用的文献

1
The changing opioid crisis: development, challenges and opportunities.不断变化的阿片类药物危机:发展、挑战与机遇。
Mol Psychiatry. 2021 Jan;26(1):218-233. doi: 10.1038/s41380-020-0661-4. Epub 2020 Feb 4.
2
Personalizing the Treatment of Substance Use Disorders.个性化物质使用障碍的治疗
Am J Psychiatry. 2020 Feb 1;177(2):113-116. doi: 10.1176/appi.ajp.2019.19121284.
3
Rural Veterans Less Likely to Get Medication for Opioid Use Disorder.农村退伍军人获得阿片类物质使用障碍药物治疗的可能性较小。
Promoting Health Equity Among People With Opioid Use Disorder and Serious Mental Illness Through the Chronic Disease Self-Management Program.
通过慢性病自我管理项目促进阿片类药物使用障碍和严重精神疾病患者的健康公平。
Subst Use. 2025 May 30;19:29768357251342749. doi: 10.1177/29768357251342749. eCollection 2025 Jan-Dec.
4
Scaling up low barrier wound care for people who use drugs: a mixed methods study.扩大针对吸毒者的低门槛伤口护理服务:一项混合方法研究。
Harm Reduct J. 2025 May 21;22(1):84. doi: 10.1186/s12954-025-01241-9.
5
Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis.在退伍军人健康管理局初级保健中实施丁丙诺啡治疗阿片类药物使用障碍:一项定性分析。
Addict Sci Clin Pract. 2025 Apr 30;20(1):38. doi: 10.1186/s13722-025-00568-9.
6
Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration.阿片类药物使用障碍药物实施干预对退伍军人健康管理局住院和急诊科利用情况的影响。
BMC Psychiatry. 2025 Mar 26;25(1):288. doi: 10.1186/s12888-025-06722-6.
7
Receipt of medications for opioid use disorder among rural and urban veterans health administration patients.农村和城市退伍军人健康管理局患者中用于阿片类药物使用障碍的药物接收情况。
Drug Alcohol Depend Rep. 2024 Dec 14;14:100311. doi: 10.1016/j.dadr.2024.100311. eCollection 2025 Mar.
8
Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022.2005 - 2022年退伍军人健康管理局阿片类药物使用障碍趋势
JAMA Netw Open. 2024 Dec 2;7(12):e2451821. doi: 10.1001/jamanetworkopen.2024.51821.
9
The Association Between Chronic Pain, Substance use, and Primary Care Experience Among Veterans with Ongoing or Recent Homelessness.有持续或近期无家可归经历的退伍军人中慢性疼痛、物质使用与初级保健体验之间的关联。
J Gen Intern Med. 2024 Dec;39(16):3172-3181. doi: 10.1007/s11606-024-09078-x. Epub 2024 Oct 15.
10
Engaging healthcare teams to increase access to medications for opioid use disorder.让医疗团队参与进来,以增加阿片类药物使用障碍药物的可及性。
Health Serv Res. 2024 Dec;59 Suppl 2(Suppl 2):e14371. doi: 10.1111/1475-6773.14371. Epub 2024 Sep 8.
JAMA. 2020 Jan 28;323(4):300. doi: 10.1001/jama.2019.21856.
4
Completing the MISSION: a Blueprint for Helping Veterans Make the Most of New Choices.完成使命:帮助退伍军人充分利用新选择的蓝图。
J Gen Intern Med. 2020 May;35(5):1567-1570. doi: 10.1007/s11606-019-05404-w. Epub 2019 Oct 24.
5
Patient perspectives on alcohol use disorder pharmacotherapy and integration of treatment into primary care settings.患者对酒精使用障碍药物治疗的看法以及将治疗纳入初级保健环境的看法。
Subst Abus. 2019;40(4):501-509. doi: 10.1080/08897077.2019.1576089. Epub 2019 Mar 4.
6
Trends In Buprenorphine Prescribing By Physician Specialty.医生专业的丁丙诺啡处方趋势。
Health Aff (Millwood). 2019 Jan;38(1):24-28. doi: 10.1377/hlthaff.2018.05145.
7
Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.推进阿片类药物使用障碍的药理学治疗(ADaPT-OUD):在表现不佳的机构中为患有阿片类药物使用障碍的退伍军人改善药物辅助治疗实施的新策略的测试方案。
Addict Sci Clin Pract. 2018 Dec 13;13(1):25. doi: 10.1186/s13722-018-0127-z.
8
Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations.共病性慢性疼痛和阿片类药物使用障碍:文献综述及潜在治疗创新。
Int Rev Psychiatry. 2018 Oct;30(5):136-146. doi: 10.1080/09540261.2018.1514369. Epub 2018 Nov 6.
9
Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration.当前,退伍军人健康管理局在利用临床能力为阿片类药物使用障碍患者提供丁丙诺啡治疗方面未充分发挥作用。
Subst Abus. 2018;39(3):286-288. doi: 10.1080/08897077.2018.1509251. Epub 2018 Oct 16.
10
A crisis of opioids and the limits of prescription control: United States.阿片类药物危机和处方控制的局限性:美国。
Addiction. 2019 Jan;114(1):169-180. doi: 10.1111/add.14394. Epub 2018 Aug 27.